Lynn Sadowski-Mason has served as Brooklyn’s Executive Vice President of Clinical Operations since 2019, and was employed by Brooklyn (and its predecessor, IRX Therapeutics) in the capacities as Vice President, Clinical Operations and as Senior Director, Clinical Operations since 2017. Prior to her service with Brooklyn, Ms. Sadowski-Mason was employed at Bristol-Myers Squibb from 2005 through 2017, most recently as Director, Global Clinical Operations and Strategy. Before joining Bristol-Myers Squibb, Ms. Sadowski Mason worked for Sention, Inc. and Averion, Inc. (formerly Boston Biosciences) in various clinical research positions. Ms. Sadowski-Mason received her Bachelor of Science in Biology and Pre-Medicine from Indiana University and her Masters of Science in Regulatory Affairs at the Massachusetts College of Pharmacy and Health Sciences